LUKAS SCHEIBLER - Chief Research Officer at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Research Officer
Issuer Symbol
APLS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by LUKAS SCHEIBLER since 13 Mar 2025

Holdings reported by LUKAS SCHEIBLER for Apellis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 68,299 $4,349,963 $63.69 01 Dec 2023 Direct
Stock Option (Right to Buy) 39,391 $2,611,623 $66.30 01 Dec 2023 Direct Common Stock

Transactions reported by LUKAS SCHEIBLER for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.